Summary
This 8-K filing by CVS HEALTH Corp (CVS) on January 23, 2006, announces a significant strategic move: the acquisition of approximately 700 standalone drugstores and a distribution center from Albertson's, Inc. for a total purchase price of $3.93 billion ($2.93 billion for assets and $1.0 billion for owned real estate). This acquisition is structured as an asset purchase and is a key event for investors to note regarding CVS's expansion and market share growth strategy. The acquisition is part of a larger transaction where Albertson's is merging with SUPERVALU, INC. CVS's purchase is contingent on customary closing conditions, including regulatory approvals like the Hart-Scott-Rodino Act waiting period, and the successful completion of the Albertson's-SUPERVALU merger. The acquired "Standalone Drug Business" primarily operates in key markets like southern California, Illinois, Arizona, and others, indicating a focused geographic expansion for CVS.
Key Highlights
- 1CVS Corporation entered into an Asset Purchase Agreement to acquire approximately 700 standalone drugstores and a distribution center from Albertson's, Inc.
- 2The total purchase price for the acquisition is $3.93 billion, comprising $2.93 billion for the drugstores and distribution center, and $1.0 billion for owned real estate.
- 3The acquired business, referred to as the 'Standalone Drug Business,' is located primarily in southern California, Illinois, Arizona, Indiana, Nevada, Missouri, Wisconsin, and Kansas.
- 4The acquisition is structured as an asset purchase.
- 5CVS's acquisition is contingent upon customary closing conditions, including the Hart-Scott-Rodino Act approval.
- 6The transaction is linked to Albertson's concurrent merger agreement with SUPERVALU, INC., with CVS's acquisition subject to the completion of this merger.
- 7David B. Rickard, EVP, CFO, and Chief Administrative Officer of CVS, signed the filing.